BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 30526655)

  • 1. TNFα expressed on the surface of microparticles modulates endothelial cell fate in rheumatoid arthritis.
    Barbati C; Vomero M; Colasanti T; Diociaiuti M; Ceccarelli F; Ferrigno S; Finucci A; Miranda F; Novelli L; Perricone C; Spinelli FR; Truglia S; Conti F; Valesini G; Alessandri C
    Arthritis Res Ther; 2018 Dec; 20(1):273. PubMed ID: 30526655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of autophagy and increase in apoptosis correlates with a favorable clinical outcome in patients with rheumatoid arthritis treated with anti-TNF drugs.
    Vomero M; Manganelli V; Barbati C; Colasanti T; Capozzi A; Finucci A; Spinelli FR; Ceccarelli F; Perricone C; Truglia S; Morrone S; Maggio R; Misasi R; Bombardieri M; Di Franco M; Conti F; Sorice M; Valesini G; Alessandri C
    Arthritis Res Ther; 2019 Jan; 21(1):39. PubMed ID: 30696478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial activation and injury by microparticles in patients with systemic lupus erythematosus and rheumatoid arthritis.
    Atehortúa L; Rojas M; Vásquez G; Muñoz-Vahos CH; Vanegas-García A; Posada-Duque RA; Castaño D
    Arthritis Res Ther; 2019 Jan; 21(1):34. PubMed ID: 30674349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered profile of circulating microparticles in rheumatoid arthritis patients.
    Rodríguez-Carrio J; Alperi-López M; López P; Alonso-Castro S; Carro-Esteban SR; Ballina-García FJ; Suárez A
    Clin Sci (Lond); 2015 Apr; 128(7):437-48. PubMed ID: 25369551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of autophagy by etanercept treatment results in TNF-induced apoptosis reduction in EA.hy926 endothelial cell line.
    Barbati C; Colasanti T; Vomero M; Ceccarelli F; Celia AI; Perricone C; Spinelli FR; Conti F; Valesini G; Alessandri C
    Clin Exp Rheumatol; 2021; 39(3):606-611. PubMed ID: 32896251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proportions of several types of plasma and urine microparticles are increased in patients with rheumatoid arthritis with active disease.
    Viñuela-Berni V; Doníz-Padilla L; Figueroa-Vega N; Portillo-Salazar H; Abud-Mendoza C; Baranda L; González-Amaro R
    Clin Exp Immunol; 2015 Jun; 180(3):442-51. PubMed ID: 25639560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normalization of A2A and A3 adenosine receptor up-regulation in rheumatoid arthritis patients by treatment with anti-tumor necrosis factor alpha but not methotrexate.
    Varani K; Massara A; Vincenzi F; Tosi A; Padovan M; Trotta F; Borea PA
    Arthritis Rheum; 2009 Oct; 60(10):2880-91. PubMed ID: 19790066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between autophagy and inflammation in patients with rheumatoid arthritis receiving biologic therapy.
    Chen YM; Chang CY; Chen HH; Hsieh CW; Tang KT; Yang MC; Lan JL; Chen DY
    Arthritis Res Ther; 2018 Dec; 20(1):268. PubMed ID: 30518408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etanercept increases tumor necrosis factor-alpha level but not sFas level in patients with rheumatoid arthritis.
    Kotyla P; Jankiewicz-Ziobro K; Owczarek A; Kucharz EJ
    Isr Med Assoc J; 2015 Jan; 17(1):14-8. PubMed ID: 25739170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating microparticles remain associated with complement activation despite intensive anti-inflammatory therapy in early rheumatoid arthritis.
    van Eijk IC; Tushuizen ME; Sturk A; Dijkmans BA; Boers M; Voskuyl AE; Diamant M; Wolbink GJ; Nieuwland R; Nurmohamed MT
    Ann Rheum Dis; 2010 Jul; 69(7):1378-82. PubMed ID: 19919943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone metabolism changes during anti-TNF-alpha therapy in patients with active rheumatoid arthritis.
    Seriolo B; Paolino S; Sulli A; Ferretti V; Cutolo M
    Ann N Y Acad Sci; 2006 Jun; 1069():420-7. PubMed ID: 16855169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: a clue to interpret different chances of relapse after clinical remission?
    Alivernini S; Tolusso B; Petricca L; Bui L; Di Sante G; Peluso G; Benvenuto R; Fedele AL; Federico F; Ferraccioli G; Gremese E
    Ann Rheum Dis; 2017 Jul; 76(7):1228-1236. PubMed ID: 28119289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microparticles and autophagy: a new frontier in the understanding of atherosclerosis in rheumatoid arthritis.
    Barbati C; Vomero M; Colasanti T; Ceccarelli F; Marcosano M; Miranda F; Novelli L; Pecani A; Perricone C; Spinelli FR; Truglia S; Conti F; Valesini G; Alessandri C
    Immunol Res; 2018 Dec; 66(6):655-662. PubMed ID: 30574665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor alpha blockade treatment down-modulates the increased systemic and local expression of Toll-like receptor 2 and Toll-like receptor 4 in spondylarthropathy.
    De Rycke L; Vandooren B; Kruithof E; De Keyser F; Veys EM; Baeten D
    Arthritis Rheum; 2005 Jul; 52(7):2146-58. PubMed ID: 15986373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histological analysis of synovium by treatment of etanercept for rheumatoid arthritis.
    Suzuki Y; Inoue K; Chiba J; Inoue Y; Kanbe K
    Int J Rheum Dis; 2009 Apr; 12(1):7-13. PubMed ID: 20374310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral blood lymphocytes from patients with rheumatoid arthritis are differentially sensitive to apoptosis induced by anti-tumour necrosis factor-alpha therapy.
    Coury F; Ferraro-Peyret C; Le Cam S; Guerin S; Tebib J; Sibilia J; Bienvenu J; Fabien N
    Clin Exp Rheumatol; 2008; 26(2):234-9. PubMed ID: 18565243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of lipoprotein(a) and E-selectin are reduced in rheumatoid arthritis patients treated with methotrexate or methotrexate in combination with TNF-α-inhibitor.
    Hjeltnes G; Hollan I; Førre O; Wiik A; Lyberg T; Mikkelsen K; Agewall S
    Clin Exp Rheumatol; 2013; 31(3):415-21. PubMed ID: 23465067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulation of RasGRP1 in rheumatoid arthritis and modulation of RasGRP3 as a biomarker of TNFα inhibitors.
    Golinski ML; Vandhuick T; Derambure C; Fréret M; Lecuyer M; Guillou C; Hiron M; Boyer O; Le Loët X; Vittecoq O; Lequerré T
    Arthritis Res Ther; 2015 Dec; 17():382. PubMed ID: 26714738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunomodulatory effects of TNF-α inhibitors on human Th17 cells via RORγt histone acetylation.
    Lin YC; Lin YC; Wu CC; Huang MY; Tsai WC; Hung CH; Kuo PL
    Oncotarget; 2017 Jan; 8(5):7559-7571. PubMed ID: 27926504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of 24 months of anti-TNF therapy versus methotrexate on body weight in patients with rheumatoid arthritis: a prospective observational study.
    Sfriso P; Caso F; Filardo GS; Botsios C; Costa L; Scarpa R; Todesco S; Spinella P; Oliviero F; Punzi L
    Clin Rheumatol; 2016 Jun; 35(6):1615-8. PubMed ID: 27048267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.